Journalism begins where hype ends

,,

We’re creating alien beings. I’m willing to be selfish and choose humans"

—Geoffrey Hinton, 'Godfather of AI'

Zuckerberg’s Biohub Teams with Google, US Government in $1.8B Push for AI biological data

Two people are pictured during a Biohub discussion, with the Biohub logo visible above them.

The collaboration aims to generate large-scale biological data for predictive AI models and advance the development of a “virtual cell.” Google DeepMind, Isomorphic Labs and Meta are collectively investing $300 million in the Virtual Biology Initiative.

DeepMind and Isomorphic Labs Pitch “Bioresilience” Plan to Keep AI Out of Bioweapon Hands

DeepMind's AlphaFold protein-structure prediction anchors the "response" pillar of the bioresilience plan, which the companies say can speed up vaccine and treatment development.

Google DeepMind and Isomorphic Labs have set out a joint “bioresilience” approach aimed at stopping threat actors from misusing their AI models to develop biological weapons.

AI Meets Big Pharma: Isomorphic Labs Raises $2.1 Billion for AI Drug Discovery

Isomorphic Labs, founded in 2021 by DeepMind chief Demis Hassabis, has raised $2.1 billion in Series B funding to scale its AI-driven drug discovery platform.

Demis Hassabis’s AI drug discovery startup Isomorphic Labs has raised $2.1 billion in a Thrive Capital-led Series B, joined by Alphabet, GV, MGX, Temasek, CapitalG and the UK Sovereign AI Fund.